Old Web
English
Sign In
Acemap
>
authorDetail
>
Chihiro Ando
Chihiro Ando
Okayama University
Cancer research
Medicine
Lung cancer
Epidermal growth factor receptor
Anaplastic lymphoma kinase
4
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
2021
Cancer Science
Hiromi Watanabe
Eiki Ichihara
Hiroe Kayatani
Go Makimoto
Kiichiro Ninomiya
Kazuya Nishii
Hisao Higo
Chihiro Ando
Sachi Okawa
Takamasa Nakasuka
Hirohisa Kano
Naofumi Hara
Atsuko Hirabae
Yuka Kato
Takashi Ninomiya
Toshio Kubo
Kammei Rai
Kadoaki Ohashi
Katsuyuki Hotta
Masahiro Tabata
Yoshinobu Maeda
Katsuyuki Kiura
Show All
Source
Cite
Save
Citations (1)
SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non–small Cell Lung Cancer
2021
Molecular Cancer Therapeutics
Hirohisa Kano
Eiki Ichihara
Hiromi Watanabe
Kazuya Nishii
Chihiro Ando
Takamasa Nakasuka
Kiichiro Ninomiya
Yuka Kato
Toshio Kubo
Kammei Rai
Kadoaki Ohashi
Katsuyuki Hotta
Masahiro Tabata
Yoshinobu Maeda
Katsuyuki Kiura
Show All
Source
Cite
Save
Citations (0)
Granulation Tissue-induced Pseudo-relapse During Nivolumab Treatment in Advanced Non-small Cell Lung Cancer
2019
in Vivo
Chihiro Ando
Eiki Ichihara
Hirohisa Kano
Yoshitaka Iwamoto
Atsuko Hirabae
Takamasa Nakasuka
Yoshinobu Maeda
Katsuyuki Kiura
Show All
Source
Cite
Save
Citations (1)
Efficacy of afatinib treatment for lung adenocarcinoma harboring exon 18 delE709_T710insD mutation
2019
Japanese Journal of Clinical Oncology
Yoshitaka Iwamoto
Eiki Ichihara
Naofumi Hara
Takamasa Nakasuka
Chihiro Ando
Takahiro Umeno
Atsuko Hirabae
Yoshinobu Maeda
Katsuyuki Kiura
Show All
Source
Cite
Save
Citations (7)
1
map